AINDEX
Markets

NextCure, Inc. (NXTC)

NXTCNASDAQ-GSBiotechnology: Pharmaceutical Preparations

$6.29

-0.4130 (-6.16%) today

At the close, Nov 18, 4:00 PM ET. After hours $6.29 -8.69%

-6.16% 1D
Market cap
$31.53m
P/E
–
EPS, last 4 quarters
$-6.19
Dividend yield
–
Day range
$6.38 to $7.02
52-week range
$1.55 to $15.74
Average volume
–
Previous close
$6.70

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue––––
Gross profit––––
Operating income-$9.76m-$10.11m-$15.09m-$6.92m
Net income-$9.44m-$9.80m-$14.89m-$6.85m

The company

NextCure is a biopharmaceutical company focused on managing its legacy clinical and intellectual property assets, pursuing opportunities to maximize those legacy assets, fulfilling ongoing obligations under its existing collaboration and licensing agreements and advancing completion of the Merger with Avere.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.